OBJECTIVE: Obesity is characterized by chronic inflammation of adipose tissue, which contributes to insulin resistance and diabetes. Although nitric oxide (NO) signaling has antiinflammatory effects in the vasculature, whether reduced NO contributes to adipose tissue inflammation is unknown. We sought to determine whether (1) obesity induced by high-fat (HF) diet reduces endothelial nitric oxide signaling in adipose tissue, (2) reduced endothelial nitric oxide synthase (eNOS) signaling is sufficient to induce adipose tissue inflammation independent of diet, and (3) increased cGMP signaling can block adipose tissue inflammation induced by HF feeding. METHODS AND RESULTS: Relative to mice fed a low-fat diet, an HF diet markedly reduced phospho-eNOS and phospho-vasodilator-stimulated phosphoprotein (phospho-VASP), markers of vascular NO signaling. Expression of proinflammatory cytokines was increased in adipose tissue of eNOS-/- mice. Conversely, enhancement of signaling downstream of NO by phosphodiesterase-5 inhibition using sildenafil attenuated HF-induced proinflammatory cytokine expression and the recruitment of macrophages into adipose tissue. Finally, we implicate a role for VASP, a downstream mediator of NO-cGMP signaling in mediating eNOS-induced antiinflammatory effects because VASP-/- mice recapitulated the proinflammatory phenotype displayed by eNOS-/- mice. CONCLUSIONS: These results imply a physiological role for endothelial NO to limit obesity-associated inflammation in adipose tissue and hence identify the NO-cGMP-VASP pathway as a potential therapeutic target in the treatment of diabetes.
OBJECTIVE:Obesity is characterized by chronic inflammation of adipose tissue, which contributes to insulin resistance and diabetes. Although nitric oxide (NO) signaling has antiinflammatory effects in the vasculature, whether reduced NO contributes to adipose tissue inflammation is unknown. We sought to determine whether (1) obesity induced by high-fat (HF) diet reduces endothelial nitric oxide signaling in adipose tissue, (2) reduced endothelial nitric oxide synthase (eNOS) signaling is sufficient to induce adipose tissue inflammation independent of diet, and (3) increased cGMP signaling can block adipose tissue inflammation induced by HF feeding. METHODS AND RESULTS: Relative to mice fed a low-fat diet, an HF diet markedly reduced phospho-eNOS and phospho-vasodilator-stimulated phosphoprotein (phospho-VASP), markers of vascular NO signaling. Expression of proinflammatory cytokines was increased in adipose tissue of eNOS-/- mice. Conversely, enhancement of signaling downstream of NO by phosphodiesterase-5 inhibition using sildenafil attenuated HF-induced proinflammatory cytokine expression and the recruitment of macrophages into adipose tissue. Finally, we implicate a role for VASP, a downstream mediator of NO-cGMP signaling in mediating eNOS-induced antiinflammatory effects because VASP-/- mice recapitulated the proinflammatory phenotype displayed by eNOS-/- mice. CONCLUSIONS: These results imply a physiological role for endothelial NO to limit obesity-associated inflammation in adipose tissue and hence identify the NO-cGMP-VASP pathway as a potential therapeutic target in the treatment of diabetes.
Authors: Hunter C Champion; Trinity J Bivalacqua; Eiki Takimoto; David A Kass; Arthur L Burnett Journal: Proc Natl Acad Sci U S A Date: 2005-01-24 Impact factor: 11.205
Authors: Stuart P Weisberg; Daniel McCann; Manisha Desai; Michael Rosenbaum; Rudolph L Leibel; Anthony W Ferrante Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Lihua Chen; Günter Daum; Kanchan Chitaley; Scott A Coats; Daniel F Bowen-Pope; Martin Eigenthaler; Naresh R Thumati; Ulrich Walter; Alexander W Clowes Journal: Arterioscler Thromb Vasc Biol Date: 2004-06-03 Impact factor: 8.311
Authors: Paolo Serafini; Kristen Meckel; Michael Kelso; Kimberly Noonan; Joseph Califano; Wayne Koch; Luigi Dolcetti; Vincenzo Bronte; Ivan Borrello Journal: J Exp Med Date: 2006-11-13 Impact factor: 14.307
Authors: H Chen; O Charlat; L A Tartaglia; E A Woolf; X Weng; S J Ellis; N D Lakey; J Culpepper; K J Moore; R E Breitbart; G M Duyk; R I Tepper; J P Morgenstern Journal: Cell Date: 1996-02-09 Impact factor: 41.582
Authors: Jessica L Fry; Leona Al Sayah; Robert M Weisbrod; Isabelle Van Roy; Xiang Weng; Richard A Cohen; Markus M Bachschmid; Francesca Seta Journal: Hypertension Date: 2016-07-18 Impact factor: 10.190
Authors: Andrew M Cheng; Norma Rizzo-DeLeon; Carole L Wilson; Woo Je Lee; Sanshiro Tateya; Alexander W Clowes; Michael W Schwartz; Francis Kim Journal: Am J Physiol Endocrinol Metab Date: 2014-08-12 Impact factor: 4.310
Authors: Frank T Spradley; Jennifer M Sasser; Jacqueline B Musall; Jennifer C Sullivan; Joey P Granger Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-08-17 Impact factor: 3.619
Authors: Thomas J Jurrissen; Ryan D Sheldon; Michelle L Gastecki; Makenzie L Woodford; Terese M Zidon; R Scott Rector; Victoria J Vieira-Potter; Jaume Padilla Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-02-10 Impact factor: 3.619
Authors: Brian P Dick; Ryan McMahan; Taft Knowles; Lev Becker; Sina A Gharib; Tomas Vaisar; Tomasz Wietecha; Kevin D O'Brien; Karin E Bornfeldt; Alan Chait; Francis Kim Journal: Arterioscler Thromb Vasc Biol Date: 2020-01-30 Impact factor: 8.311
Authors: Caitlin A Dow; Brian L Stauffer; Jared J Greiner; Christopher A DeSouza Journal: Appl Physiol Nutr Metab Date: 2015-03-03 Impact factor: 2.665
Authors: J Merino; I Megias-Rangil; R Ferré; N Plana; J Girona; A Rabasa; G Aragonés; A Cabré; A Bonada; M Heras; L Masana Journal: Obes Surg Date: 2013-01 Impact factor: 4.129